GlobeNewswire

Vicor announces bidirectional 48V/12V NBM Converter for data center and automotive applications

Dela

Vicor to show new Non-isolated Bus Converter Modules at the PCIM 2018 conference in Nuremberg, Germany

NUREMBERG, Germany, June 05, 2018 (GLOBE NEWSWIRE) -- Vicor Corporation (NASDAQ:VICR) today announced a bidirectional non-isolated fixed-ratio converter for hybrid 48V/12V power systems in data center and automotive applications.

The 2317 NBM is a bidirectional converter capable of providing up to 750W continuously at 48V from 12V, or at 12V from 48V, with over 98% peak efficiency. With up to 1kW of peak power capability (for up to 2ms) in a 23 x 17 x 7mm surface-mount package, the NBM (NBM2317S54D1464T0R) provides a complete solution with no external circuitry needed. By switching at 2MHz, the NBM provides low output impedance and fast transient response to dynamic loads. The NBM incorporates hot-swap and inrush current limiting, increasing power system density and saving valuable board space, time and money.

In data centers that are still relying on legacy 12V distribution, the NBM supports state-of-the-art 48V input GPUs using Power-on-Package ("PoP") Modular Current Multipliers ("MCMs") driven from a 48V node sourcing a small fraction (1/48) of the GPU current. Current multiplication overcomes the power delivery boundaries imposed by traditional 12V systems that limit higher bandwidth and connectivity. In data centers that have been upgraded to a 48V infrastructure, the NBM can be used to support legacy 12V loads.

In mild hybrid and autonomous vehicles using 48V, the NBM supports legacy 12V subsystems from efficient power distribution at 48V with or without dual batteries.

Learn more about the Vicor 2317 NBM and Power-on-Package current multipliers

About Power-on-Package
The Vicor PoP modules build upon Factorized Power Architecture (FPA) systems deployed in high-performance computers and large-scale data centers. FPA provides efficient power distribution and direct conversion from 48V to 1V for GPUs, CPUs and ASICs demanding up to 1,000A. By deploying current multiplication in close proximity to high-current Artificial Intelligence (AI) processors, PoP MCMs enable higher performance and system efficiency.

Follow Vicor on Social Media
Twitter: @VicorPower »
Vicor Corporation on LinkedIn »
Vicor PowerBlog »

About Vicor Corporation
Headquartered in Andover, Massachusetts, Vicor Corporation, manufactures and markets innovative, high-performance modular power components, from power modules to semiconductor-centric solutions, to enable customers to efficiently convert and manage power from the power source to the point of load.www.vicorpower.com

Power Component Design Methodology
Vicor Power Component Design Methodology enables power system designers to reap all of the benefits of modular power component design - predictable component and system functionality and reliability, fast design cycles, and easy system configurability, re-configurability and scaling - while achieving system operating efficiency, power density and economy that rival the best alternative solutions. Utilizing Vicor Power System Designer, engineers can select from an extensive portfolio of proven Vicor power components to architect, optimize and simulate their complete power system, all the way from their input sources to their points of load. This innovative approach to power system design delivers fast time-to-market and state-of-the-art performance while minimizing the possibility of last minute surprises and delays that so often occur with conventional or custom design methodologies.

Vicor, NBM and FPA are trademarks of Vicor Corporation.

Contact
Colin Boroski
Rainier Communications
508-475-0025 x 142
cboroski@rainierco.com 

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/d319158f-48ce-488d-955a-129354658bef




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Vicor Corporation via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Oboya signs a cooperation agreement with Gaia regarding biomaterials13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") has signed an important and long-term cooperation agreement on environmentally friendly biomaterials with Gaia Biomaterials AB ("Gaia") in Helsingborg, Sweden. The agreement means that Oboya uses Gaias biomaterials for the production and development of environmentally friendly cultivation products for the cultivation industry. Oboya has been actively involved in innovation, environmental and sustainability issues in recent years, and our goal is to encourage environmental and sustainability in the cultivation industry by offering environmentally friendly cultivation products to our customers. Oboya believes that the use of biomaterials will be important for success in the conversion to a fossil-free cultivation industry worldwide. The cooperation agreement means that Oboya uses Gaias biomaterials in its production and that through Gaias expertise we can develop new environmentally friendly cultivation products. Gaias biomaterials are bi

Oboya tecknar ett samarbetsavtal med Gaia avseende biomaterial13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") har tecknat ett viktigt och långsiktigt samarbetsavtal avseende miljövänligt biomaterial med Gaia Biomaterials AB ("Gaia") i Helsingborg, Sverige. Avtalet innebär att Oboya använder Gaias biomaterial för tillverkning och utveckling av miljövänliga odlingsprodukter till odlingsindustrin. Oboya har under de senaste åren arbetat aktivt med innovation, miljö- och hållbarhetsfrågor och vårt mål är att främja miljö och hållbarhet inom odlingsindustrin genom att erbjuda miljövänliga odlingsprodukter till våra kunder. Oboya anser att användningen av biomaterial kommer att vara viktigt för framgång i omställningen till en fossilfri odlingsindustri världen över. Samarbetsavtalet innebär att Oboya använder Gaias biomaterial i sin produktion och att vi genom Gaias kompetens kan utveckla nya miljövänliga odlingsprodukter. Gaias biomaterial är biologiskt nedbrytbart, komposterbart samt ger upp till 80 % lägre koldioxidutsläpp vid förbränning jämfört

Stillfront: Simutronics reclaims publishing services10.12.2018 14:11Pressmeddelande

PRESS RELEASE December 10, 2018 Simutronics reclaims the publishing services for SIEGE: Titan Wars globally except China Simutronics Corp, a studio within Stillfront Group AB, has ended a co-publishing agreement regarding the mobile game SIEGE: Titan Wars with New York based publishing partner Tilting Point. According to a new agreement, Tilting Point will continue to provide publishing services and market the game in China but Simutronics will run the publishing services and marketing globally from the Group going forward. Simutronics is a leading developer of online roleplaying and mobile games such as DragonRealms, GemStone IV and Lara Croft Relic Run, the latter with more than 23 million downloads. Tilting Point is a new-generation games partner that provides top development studios with expert resources, services, and operational support to optimize high quality live games for success. "I am very pleased to continue the partnership with Tilting Point for the Chinese market as this

Stillfront: Simutronics återtar förläggartjänster10.12.2018 14:11Pressmeddelande

PRESSMEDDELANDE 2018-12-10 Simutronics återtar förläggartjänster för SIEGE: Titan Wars globalt med undantag för Kina Simutronics, en studio inom Stillfront Group, har avslutat ett medförläggaravtal avseende mobilspelet SIEGE: Titan Wars med den New York-baserade förläggarpartnern Tilting Point. Enligt ett nytt avtal kommer Tilting Point fortsatt att tillhandahålla förläggartjänster och marknadsföring av spelet i Kina men på global nivå kommer Simutronics att ansvara för förläggartjänster och marknadsföring av spelet från gruppen. Simutronics är en ledande utvecklare av rollspel och mobila spel som till exempel DragonRealms, GemStone IV och Lara Croft Relic Run, den sistnämnda med mer än 23 miljoner nedladdningar. Tilting Point är den nya generationens spelbolagspartner som förser ledande utvecklingsstudios med expertis, tjänster och operationell support för att optimera högkvalitativa livespel framgångsrikt. "Jag är mycket nöjd över det fortsatta partnerskapet med Tilting Point för den

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum